|
RNF216L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.855030E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.794000E-01 |
| Normal-vs-Stage2 |
6.022400E-01 |
| Normal-vs-Stage3 |
4.031000E-01 |
| Normal-vs-Stage4 |
5.547900E-02 |
| Stage1-vs-Stage2 |
9.252600E-01 |
| Stage1-vs-Stage3 |
8.857400E-01 |
| Stage1-vs-Stage4 |
1.461560E-01 |
| Stage2-vs-Stage3 |
9.876200E-01 |
| Stage2-vs-Stage4 |
3.939600E-01 |
| Stage3-vs-Stage4 |
2.178400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.200400E-01 |
| Normal-vs-AfricanAmerican |
1.661370E-01 |
| Normal-vs-Asian |
4.580000E-02 |
| Caucasian-vs-AfricanAmerican |
3.968600E-01 |
| Caucasian-vs-Asian |
2.964800E-03 |
| AfricanAmerican-vs-Asian |
1.570010E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.954210E-01 |
| Normal-vs-Female |
2.990800E-01 |
| Male-vs-Female |
8.557400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.195600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.973000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.727640E-01 |
| Normal-vs-Age(81-100Yrs) |
4.277000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.665800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.306600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.905980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.747400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.564960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.466980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.738100E-02 |
| Normal-vs-Grade 2 |
6.369600E-01 |
| Normal-vs-Grade 3 |
5.547400E-01 |
| Normal-vs-Grade 4 |
1.767590E-02 |
| Grade 1-vs-Grade 2 |
1.577960E-01 |
| Grade 1-vs-Grade 3 |
1.933610E-01 |
| Grade 1-vs-Grade 4 |
8.292000E-01 |
| Grade 2-vs-Grade 3 |
8.738000E-01 |
| Grade 2-vs-Grade 4 |
2.650500E-02 |
| Grade 3-vs-Grade 4 |
3.369600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.929600E-01 |
| Normal-vs-ccB subtype |
1.954250E-02 |
| ccA subtype-vs-ccB subtype |
2.641700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.734400E-02 |
| Normal-vs-N1 |
2.438800E-01 |
| N0-vs-N1 |
4.456200E-01 |
|
|
